Cambrex has appointed Troy Player as president, early stage development and testing (ESDT). Troy has responsibility for operations at the Agawam, MA; Durham, NC; Edinburgh, UK; High Point, NC and Longmont, CO facilities.
Troy has more than 25 years of experience in senior strategic and operational executive roles with a track record of developing, driving and managing business improvement. He joins the company from West Pharmaceuticals where he spent 17 years and was most recently Vice President and General Manager of the Contract Manufacturing Business Unit, overseeing six manufacturing locations and two engineering development centers. Prior to this he was Vice President and Managing Director for their Asia Pacific Region.
“I am pleased to welcome an operational excellence and continuous improvement expert like Troy to our team,” commented Shawn Cavanagh, President and Chief Operating Officer at Cambrex. “He is well-versed in leading cross-functional business improvement within commercial, manufacturing, customer service, business development, logistics/procurement, and product management/development environments, which makes him an invaluable asset to our team.”
The ESD&T Business Unit was integrated into the Cambrex service portfolio following the acquisition of Avista Pharma Solutions in January 2019.